Financing ·
Indaptus Therapeutics, Inc. entered into a Stock Purchase Agreement on June 17, 2026, to issue and sell 20,000,000…
INDPIndaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. entered into a Stock Purchase Agreement on June 17, 2026, to issue and sell 20,000,000 shares of common stock at $0.60 per share, raising approximately $12,000,000 in gross proceeds. The private placement was conducted offshore via Regulation S, Regulation D, and Section off-shore transactions, involving non-U.S. accredited investors. The company is obligated to register the shares via an SEC registration statement within 90 days of closing. Indaptus Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions for cancer and other diseases.